Citation Impact
Citing Papers
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer
2013
The gut microbiota and host health: a new clinical frontier
2015 Standout
Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress
2006
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
2014
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
2013
The regulation of IL-10 production by immune cells
2010 Standout
Physiological, Pharmacological, and Nutritional Regulation of Circulating Adiponectin Concentrations in Humans
2008
Monostrain, multistrain and multispecies probiotics—A comparison of functionality and efficacy
2004
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis
2013
A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis
2009
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats
2005
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Metagenomic Approaches for Defining the Pathogenesis of Inflammatory Bowel Diseases
2008
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Ulcerative Colitis
2011 Standout
Modulation of human dendritic cell phenotype and function by probiotic bacteria
2004
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
2006
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
2014
Guidelines for the management of inflammatory bowel disease in adults
2011
A comparative study of the preventative effects exerted by three probiotics,Bifidobacterium lactis,Lactobacillus caseiandLactobacillus acidophilus, in the TNBS model of rat colitis
2007
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
2004
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Malnutrition as an enteric infectious disease with long-term effects on child development
2008
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
2005
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
2014 Nature
A Proposed Classification of Ileal Pouch Disorders and Associated Complications After Restorative Proctocolectomy
2008
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
2005
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases
2009
Diagnosis and management of pouchitis1 1Abbreviations used in this paper: EIM, extraintestinal manifestations; FAP, familial adenomatous polyposis; IL, interleukin; IPAA, ileal pouch anal anastomosis; pANCA, serum antineutrophil cytoplasmic antibody-perinuclear staining pattern; PAS, Pouchitis Activity Score; PDAI, Pouchitis Disease Activity Index; PSC, primary sclerosing cholangitis; QOL, quality of life; SCFA, small chain fatty acids.
2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
2003
The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat
2008
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Revolution and evolution: 30 years of ileoanal pouch surgery
2006
Health benefits of probiotics: are mixtures more effective than single strains?
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients
2010
Pouchitis: What Every Gastroenterologist Needs to Know
2013
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis
2013
Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice
2007
Ulcerative colitis
2012 Standout
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
2007
The development of allergic inflammation
2008 StandoutNature
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun
2008
Mechanisms of action of probiotics: Recent advances
2008
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Probiotics and clinical effects: is the number what counts?
2013
Necrotizing Enterocolitis
2011 Standout
The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease
2006
Intestinal mucosal barrier function in health and disease
2009 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production
2008
Clinical guidelines for the management of pouchitis
2009
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
2009
A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis
2003
How regulatory T cells work
2008 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
The VSL# 3 Probiotic Mixture Modifies Microflora but Does Not Heal Chronic Dextran-Sodium Sulfate–Induced Colitis or Reinforce the Mucus Barrier in Mice
2005
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
2004
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse
2005
Medical therapy for ulcerative colitis 2004
2004
Ulcerative colitis
2016 Standout
Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era
2015
Effects of dietary fiber on inflammatory bowel disease
2005
Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants
2011
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
2005
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
2004
Pouchitis and Pouch Dysfunction
2009
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
2005
Human health effects of conjugated linoleic acid from milk and supplements
2011
Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice
2005
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease?: Table 1
2005
Systematic review: the management of pouchitis
2006
Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis
2001
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice
2002
Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics
2012
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era
2009
Defects in mucosal immunity leading to ulcerative colitis
2005
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
2006
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
The pros, cons, and many unknowns of probiotics
2019 Standout
Guidelines for the management of inflammatory bowel disease in adults
2004
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
2008 StandoutNature
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
2010 Standout
Irritable Bowel Syndrome
2015 Standout
Probiotics: sorting the evidence from the myths
2008
Gut Microbiota in Health and Disease
2010 Standout
PON1 and Mediterranean Diet
2015
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms
2004
Conversion of Biomass into Chemicals over Metal Catalysts
2013 Standout
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
2010
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells
2005
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
From Structure to Function: the Ecology of Host-Associated Microbial Communities
2010
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
Immunomodulation by Commensal and Probiotic Bacteria
2010
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Probiotic metabolites as epigenetic targets in the prevention of colon cancer
2012
A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch–anal anastomosis
2003
Works of Ulf Helwig being referenced
Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARγ2 P12A polymorphism: a double blind, randomized, controlled cross-over study
2009
Four‐week open‐label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis
2002
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
2003
Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with − 11388 promoter polymorphism
2007
The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols
2012
Lactobacilli, bifidobacteriaandE. colinissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells
2006
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment
2001
Effect of probiotic strains on interleukin 8 production by HT29/19A cells
2002
A Promoter Polymorphism in the Liver-specific Fatty Acid Transport Protein 5 is Associated with Features of the Metabolic Syndrome and Steatosis
2010
The association of fatty acid–binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability
2007
The minor allele of the PPARγ2 Pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men
2007
CLA Does Not Impair Endothelial Function and Decreases Body Weight as Compared with Safflower Oil in Overweight and Obese Male Subjects
2011
Prophylaxis of pouchitis onset with probiotic therapy
2003
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo controlled trial
2000
Increased expression of cytokines, inducible nitric oxide synthase and matrix metalloproteinases in pouchitis: Effects of problotic treatment
2001